HTG Molecular Diagnostics, Inc. Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program
January 23, 2019 at 04:05 pm EST
HTG Molecular Diagnostics, Inc. announced it has appointed Dr. Joseph Sparano as lead of its Breast Cancer Program Scientific Advisory Board (SAB). Dr. Joseph Sparano is Professor of Medicine & Women's Health at the Albert Einstein College of Medicine, Associate Chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center and Associate Director for Clinical Research at the Albert Einstein Cancer Center.